High materiality8/10
Collegium Pharmaceutical assumed with a Buy at Truist
Why it may matterVerify against the original reporting
Upside potential with solid target above current price.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist initiates coverage with a Buy on Collegium Pharmaceutical; target $49 vs current price $23.37.
- Collegium Buy initiation; target 49 vs price 23.37.
Key facts
- 01
Target: $49
- 02
Posted price: $23.37
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.